Healthcare Global Enterprises Ltd (HCG)
₹666.55
Mkt cap
₹9,658 Cr
P/E ratio
336.00
P/B
7.47
Div yield
0.00%
ROE
2.55%
ROCE
8.31%
EPS (TTM)
₹1.98
Book value
₹89
52W range
522–772
Sector
Healthcare
Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector. [1]
Health check
Mixed
ValuationExpensive
ProfitabilityWeak
GrowthHigh
TechnicalsBullish
52-week range
−13.61% from high₹667
₹522+27.75% from low₹772
Current
₹666.55
Prev close
₹667.00
Day
−0.07%
Price performance
1D
−0.07%
1W
+1.97%
1M
+11.02%
3M
+17.07%
6M
+4.87%
1Y
+16.59%
YTD
+2.34%
Financials
FRevenue, profit & margin
P/E ratio
336.0×
HCG is 588% above the sector median of 48.8×
HCG336.0×
Sector median48.8×
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 441.71 | 460.68 | 486.94 | 469.87 | 494.63 | 525.58 | 553.54 | 558.57 | 585.16 | 613.16 | 646.85 | 633.07 | 652.33 | |
| Expenses | 365.40 | 386.37 | 402.32 | 391.26 | 402.60 | 434.68 | 451.30 | 470.19 | 479.53 | 505.37 | 523.54 | 523.51 | 527.25 | |
| Operating Profit | 76.31 | 74.31 | 84.62 | 78.61 | 92.03 | 90.90 | 102.24 | 88.38 | 105.63 | 107.79 | 123.31 | 109.56 | 125.08 | |
| OPM % | 17.28% | 16.13% | 17.38% | 16.73% | 18.61% | 17.30% | 18.47% | 15.82% | 18.05% | 17.58% | 19.06% | 17.31% | 19.17% | |
| Other Income | 4.65 | 2.77 | 3.40 | 6.07 | 9.01 | 8.81 | 11.13 | 5.54 | 10.23 | 7.51 | 2.93 | -10.20 | -18.32 | |
| Interest | 25.63 | 25.55 | 26.89 | 29.46 | 26.84 | 33.71 | 35.98 | 40.70 | 44.17 | 45.47 | 43.62 | 44.78 | 42.70 | |
| Depreciation | 42.20 | 41.01 | 43.21 | 44.16 | 45.98 | 47.01 | 49.74 | 56.52 | 58.07 | 57.91 | 62.80 | 60.65 | 62.81 | |
| Profit before tax | 13.13 | 10.52 | 17.92 | 11.06 | 28.22 | 18.99 | 27.65 | -3.30 | 13.62 | 11.92 | 19.82 | -6.07 | 1.25 | |
| Tax % | 56.97% | 65.30% | 39.84% | 68.99% | 16.87% | 28.23% | 25.21% | -334.85% | 50.29% | 49.83% | -4.24% | 30.15% | -223.20% | |
| Net Profit | 5.65 | 3.65 | 10.78 | 3.43 | 23.46 | 13.63 | 20.68 | 7.75 | 6.77 | 5.98 | 20.66 | -7.90 | 4.04 | |
| EPS in Rs | 0.57 | 0.52 | 0.92 | 0.39 | 1.44 | 0.82 | 1.22 | 0.47 | 0.50 | 0.32 | 1.09 | -0.63 | 0.15 | |
| Raw PDF |
Earnings
EResults dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
CLast 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
Sas of Jun 202664.21%Promoter
Promoters64.21%
FIIs2.74%0.02
DIIs19.20%0.29
Public13.85%0.30
Ownership trend
Peers
P8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,934.00 | 65.68 | 1,28,457 | 0.22% | 551 | +35.86% | 6,606 | +18.12% | 17.89% |
| Max Healthcare | ₹1,102.70 | 72.35 | 1,07,320 | 0.18% | 342 | +7.28% | 2,143 | +12.21% | 14.71% |
| Fortis Health. | ₹976.15 | 69.61 | 73,695 | 0.10% | 271 | +22.42% | 2,365 | +17.81% | 13.47% |
| Aster DM Health. | ₹824.60 | 176.10 | 71,878 | 0.61% | 154 | +41.97% | 1,182 | +18.20% | 11.40% |
| Narayana Hrudaya | ₹2,037.40 | 48.88 | 41,636 | 0.22% | 224 | +12.47% | 2,594 | +75.80% | 15.36% |
| Global Health | ₹1,338.50 | 64.58 | 35,988 | 0.04% | 142 | +4.71% | 1,159 | +24.46% | 17.14% |
| Krishna Institu. | ₹807.95 | 136.82 | 33,934 | 0.00% | 33 | −50.66% | 1,075 | +34.85% | 9.29% |
| Health.Global | ₹646.85 | 335.89 | 9,658 | 0.00% | 4 | +162.36% | 652 | +11.48% | 8.31% |
| Median: 28 Co. | ₹570.30 | 48.81 | 5,461 | 0.02% | 31 | +22.42% | 353 | +22.28% | 14.76% |
Filings
DAnnual reports10
Concall transcripts82
TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptFeb 2026PPTFeb 2026PPTFeb 2026TranscriptDec 2025PPTDec 2025RECDec 2025PPTNov 2025PPTAug 2025TranscriptMay 2025PPTMay 2025TranscriptMar 2025PPTMar 2025TranscriptNov 2024PPTNov 2024TranscriptAug 2024PPTAug 2024TranscriptJun 2024PPTJun 2024PPTMay 2024TranscriptFeb 2024PPTFeb 2024
Credit ratings6
Announcements5
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 9 JulCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 3 Jul - Regulation 74(5) certificate filed for demat/remat requests in quarter ended June 30, 2026.Closure of Trading Window 30 JunAnnouncement under Regulation 30 (LODR)-Diversification / Disinvestment 29 Jun - Completed sale of 99.999% BACC stake on June 29, 2026; received INR 28.23 crore initial consideration.Suspension Of HCG KR Unit Ethics Committee (Bangalore)Approving Or Overseeing Any New Clinical Trial For A Period Of 24 Months. 17 Jun - CDSCO suspends HCG Bangalore KR ethics committee for 24 months over alleged trial review lapses.